Radioprotection of osteoblasts by a fractionated dose regimen and amifostine

Plastic and Reconstructive Surgery

Volumn 123, Issue SUPPL.2S, 2009, Pages

  Mehrara, Babak J ^a   Wong, Alex K ^a   Mei, Lily ^a   Soares, Marc A ^a   Schönmeyr, Björn H ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMIFOSTINE; VASCULOTROPIN; RADIOPROTECTIVE AGENT; VASCULOTROPIN A;

ANIMAL EXPERIMENT; BONE TISSUE; CALVARIA; CELL FUNCTION; CELL GROWTH; CELL PROTECTION; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH INHIBITION; IONIZING RADIATION; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE FRACTIONATION; RADIATION PROTECTION; RAT; ANIMAL; ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODEL; DRUG EFFECT; NEWBORN; PHYSIOLOGY; RADIATION EXPOSURE;

AMIFOSTINE; ANIMALS; ANIMALS, NEWBORN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DOSE FRACTIONATION; OSTEOBLASTS; RADIATION-PROTECTIVE AGENTS; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 61749099734     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e318191c5a0     Document Type: Conference Paper

References (30)

1. Jereczek-Fossa BA, Orecchia R. Radiotherapy-induced mandibular bone complications. Cancer Treat Rev. 2002;28:65-74.
2. Evans H, Brown S, Hurst L. The effects of early postoperative radiation on vascularized bone grafts. Ann Plast Surg 1991; 26:505.
3. Mitchell M, Logan P. Radiation induced changes in bone. Radiographics 1998;18:1125.
4. Bedwinek J, Shukovsky LJ, Fletcher GH, nd Daley TE. Os-teonecrosis in patients treated with definitive radiotherapy for squamous cell carcinomas of the oral cavity and naso- and oropharynx. Radiology 1976;119:665-667.
5. Hall EJ. Time, dose, and fractionation in radiotherapy. In Hall EJ, ed. Radiobiology for the Radiologist. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2000:397-418.
6. Andreassen CN, Grau C, Lindegaard JC. Chemical radiopro-tection: A critical review of amifostine as a cytoprotector in radiotherapy. Semin Radiat Oncol. 2003;13:62-72.
7. Grdina DJ, Murley JS, Kataoka Y. Radioprotectants: Current status and new directions. Oncology 2002;63(Suppl 2):2-10.
8. Buntzel J, Kuttner K, Frohlich D, Glatzel M. Selective cyto-protection with amifostine in concurrent radiochemo-therapy for head and neck cancer. Ann Oncol. 1998;9:505-509.
9. Bennett CL, Lane D, Stinson T, Glatzel M, Buntzel J. Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: Preliminary results from a randomized phase II clinical trial from Germany. Cancer Invest. 2001;19:107-113.
10. Peters K, Mucke R, Hamann D, Ziegler PG, Fietkau R. Supportive use of amifostine in patients with head and neck tumors undergoing radio-chemotherapy: Is it possible to limit the duration of the application of amifostine? Strahl-enther Onkol. 1999;175(Suppl 4):23-26.
11. Vacha P, Fehlauer F, Mahlmann B, et al. Randomized phase III trial of postoperative radiochemotherapy amifostine in head and neck cancer: Is there evidence for radioprotec-tion? Strahlenther Onkol. 2003;179:385-389.
12. Steinbrech DS, Mehrara BJ, Saadeh PB, et al. VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanism. Am J Physiol. 2000;278:C853-C860.
13. Spector JA, Mehrara BJ, Greenwald JA, et al. Osteoblast expression of vascular endothelial growth factor is modulated by the extracellular microenvironment. Am J Physiol. 2001; 280:C72-C80.
14. Bouletreau PJ, Warren SM, Spector JA, Steinbrech DS, Meh-rara BJ, Longaker MT. Factors in the fracture microenvironment induce primary osteoblast angiogenic cytokine production. Plast Reconstr Surg. 2002;110:139-148.
15. Steinbrech DS, Mehrara BJ, Saadeh PB, et al. Hypoxia regulates VEGF expression and cellular proliferation by osteo-blasts in vitro. Plast Reconstr Surg. 1999;104:738-747.
16. Dudziak ME, Saadeh PB, Mehrara BJ, et al. The effects of ionizing radiation on osteoblast-like cells in vitro. Plast Reconstr Surg. 2000;106:1049-1061.
17. Perthes G. Ueber den Einfluss der Rontgenstrahlen auf epi-theliale Gewebe, insbesondere auf das Carcinom. Langen-becks Arch Klin Chir. 1903;71:955.
18. Eifer PJ. Decreased bone growth arrest in weanling rats with multiple radiation fractions per day. Int J Radiat Oncol Biol Phys. 1988;15:141-145.
19. Hartsell WF, Hanson WR, Conterato DJ, Hendrickson FR. Hyperfractionation decreases the deleterious effects of conventional radiation fractionation on vertebral growth in animals. Cancer 1989;63:2452-2455.
20. Damron TA, Spadaro JA, Tamurian RM, Damron LA. Sparing of radiation-induced damage to the physis: Fractionation alone compared to amifostine pretreatment. Int J Radiat Oncol Biol Phys. 2000;47:1067-1071.
21. Forrest CR, O'Donovan DA, Yeung I, et al. Efficacy of radiopro-tection in the prevention of radiation-induced craniofacial bone growth inhibition. Plast Reconstr Surg. 2002;109:1311-1323.
22. Damron TA, Margulies B, Biskup D, Spadaro JA. Amifostine before fractionated irradiation protects bone growth in rats better than fractionation alone. Int J Radiat Oncol Biol Phys. 2001;50:479-483.
23. La Scala GC, O'Donovan DA, Yeung I, et al. Radiation-induced craniofacial bone growth inhibition: Efficacy of cyto-protection following a fractionated dose regimen. Plast Re-constr Surg. 2005;115:1973-1985.
24. Stewart FA, Rojas A. Radioprotection of mouse skin by WR-2721 in single and fractionated treatments. Br J Radiol. 1982; 55:42-47.
25. Rojas A, Stewart FA, Soranson JA, Smith KA, Denekamp J. Fractionation studies with WR-2721: Normal tissues and tumour. Radiother Oncol. 1986;6:51-60.
26. Khodarev NN, Kataoka Y, Murley JS, Weichselbaum RR, Grdina DJ. Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC). Int J Radiat Oncol Biol Phys. 2004;60:553-563.
27. Ramdas J, Warrier RP, Scher C, Larussa V. Effects of ami-fostine on clonogenic mesenchymal progenitors and hema-topoietic progenitors exposed to radiation. J Pediatr Hematol Oncol. 2003;25:19-26.
28. Srinivasan V, Pendergrass JA, Kumar KS, et al. Radioprotec-tion, pharmacokinetic, and behavioral studies in mouse implanted with biodegradable (amifostine) pellets. Int J Radiat Biol. 2002;87:535-543.
29. Muller AC, Pigrosch S, Beyer C, et al. Radioprotective effects of amifostine in vitro and in vivo measured with the comet assay. Strahlenther Onkol. 2004;180:517-525.
30. Cassatt DR, Fazenbaker CA, Bachy CM. Amifostine protects rats from mucositis resulting from a fractionated or hyper-fractionated radiation exposure. Int J Radiat Biol. 2005;61: 901-907.